SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with Lumentums fixed exchange ratio tying its deal value to Marvells share price. Traders are debating the deals value as LITE falls alongside MRVL, questioning whether the headline premium holds up as the acquirers stock weakens.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells agreement to acquire Lumentum in an all-stock deal is the dominant focus, with traders concerned about shareholder dilution, financing, and integration risks as the stock sells off. Others see strategic value in combining Marvells AI-connectivity business with Lumentums optical technology, but debate how long the benefits may take to materialize.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is drawing attention from speculation around reported MarvellLumentum acquisition talks and claims that POET appeared in Foxconns photonics ecosystem, alongside its previously disclosed FIT optical-engine collaboration. Bulls view the developments as supportive of the optics opportunity, while skeptics say they do not prove commercial shipments or purchase orders and want evidence of production execution.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to a 52-week high ahead of anticipated Q3 results has drawn attention, with traders citing BRIUMVIs sales growth and the potential of its subcutaneous formulation. Buyout and short-squeeze speculation is also prominent, though some traders see the rally as momentum around the commercial story rather than evidence of a deal.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes third-quarter results beat expectations, with strong revenue growth led by Auvelity and a narrower-than-expected loss. Traders welcomed the report and see cash-flow break-even approaching, while the lack of formal guidance drew some concern.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals European Lithium acquisition and the resulting CRML share issuance dominate discussion, with traders debating whether the added share supply will weigh on the stock or whether the deals cash and expanded asset ownership will offset it. High borrowing costs and short-interest claims are also fueling squeeze speculation, though traders disagree on whether that can counter dilution concerns.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

CIFRs quarterly results are driving discussion, with traders criticizing weak revenue and ongoing cash-generation and financing concerns despite reported progress bringing HPC leases into service. The reaction is split between fears that debt and the miner-to-AI infrastructure transition will weigh on the stock and bullish arguments that contracted leases and continued AI demand support the longer-term case.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempuss quarterly results topped expectations and management raised its full-year revenue guidance, but shares fell as traders debated whether the strong report had already been priced in. Some view the pullback as profit-taking after the beat, while others are skeptical of the companys results and post-earnings price action.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA accelerated approval of Voceryq, a competing treatment for recurrent respiratory papillomatosis, has raised concerns about competition for Precigens PAPZIMEOS. Traders debate the threat to its market share, with skeptics emphasizing Voceryqs treatment regimen and bulls pointing to Precigens commercial head start, payer access and upcoming earnings.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention after a sharp selloff alongside other AI-optics stocks, with traders pointing to broader concerns about AI spending and financing rather than a clear company-specific catalyst. The debate centers on whether the drop is an overreaction to sector pressure or reflects real risks around dilution, customer concentration, and execution; bulls cite ongoing data-center demand and the earnings report as potential tests of the growth story.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Did Globe Life Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Globe Life Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Globe Life Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Oct. 27, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We...

Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL)

Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL) Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL)PR NewswireNEW YORK, Oct. 26, 2026 Globe Life disclosed roughly...

Globe Life (GL) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Globe Life Q3 2026 Earnings Call Transcript

Globe Life (NYSE:GL) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Globe Life Q3 Earnings Miss Estimates on Weak Underwriting Income

GL's Q3 2026 earnings miss estimates as weaker underwriting income and rising expenses offset higher premiums and investment income.

Globe Life (GL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Globe Life (GL) Lags Q3 Earnings and Revenue Estimates

Globe Life (GL) delivered earnings and revenue surprises of -0.62% and -0.03%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

GLOBE LIFE INC. REPORTS THIRD QUARTER 2026 RESULTS

GLOBE LIFE INC. REPORTS THIRD QUARTER 2026 RESULTS GLOBE LIFE INC. REPORTS THIRD QUARTER 2026 RESULTSPR NewswireMCKINNEY, Texas, Oct. 21, 2026 MCKINNEY, Texas, Oct. 21, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended September 30, 2026, net income was $4.62...

GL Gains From Premium Growth, AI Adoption and Higher Investment Income

Globe Life targets stronger premium growth in 2026, backed by rising investment income, AI adoption, agency expansion and substantial shareholder returns.

Exploring Analyst Estimates for Globe Life (GL) Q3 Earnings, Beyond Revenue and EPS

Get a deeper insight into the potential performance of Globe Life (GL) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

• Reported GAAP EPS of $4.84 up 0.62% YoY
• Reported revenue of $1.6B up 5.48% YoY
• Globe Life adjusted full-year 2026 earnings guidance to $15.35 to $15.65; for 2027, Globe Life estimates net operating income per share of $16.10 to $17.10, an increase of 7.1% at the midpoint.

Globe Life reported lower net income and underwriting income, a United American health underwriting loss due primarily to Evry and CMS claims, and warned Medicare alternatives could affect traditional Medicare Supplement sales.

Globe Life reported 7% total premium growth and 16% health premium growth, estimated 2027 net operating income per share of $16.10 to $17.10, and raised 2026 repurchase guidance to $725M to $775M.

Globe Life, Inc. is an insurance holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Health Insurance, and Investments Insurance. The Life Insurance segment offers products marketed by Globe Life include traditional whole life and term life insurance. The Health Insurance segment is involved in the renewable and includes Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products. The Investments Insurance segment refers to the management of capital resources, including investments, and the management of liquidity. The company was founded on November 19, 1979, and is headquartered in McKinney, TX.

Globe Life Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

GL News